[go: up one dir, main page]

ZA200908993B - Oral pharmaceutical solutions containing telbivudine - Google Patents

Oral pharmaceutical solutions containing telbivudine

Info

Publication number
ZA200908993B
ZA200908993B ZA200908993A ZA200908993A ZA200908993B ZA 200908993 B ZA200908993 B ZA 200908993B ZA 200908993 A ZA200908993 A ZA 200908993A ZA 200908993 A ZA200908993 A ZA 200908993A ZA 200908993 B ZA200908993 B ZA 200908993B
Authority
ZA
South Africa
Prior art keywords
telbivudine
solutions containing
oral pharmaceutical
pharmaceutical solutions
oral
Prior art date
Application number
ZA200908993A
Other languages
English (en)
Inventor
Nabila Sekkat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38724394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200908993(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200908993B publication Critical patent/ZA200908993B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200908993A 2007-07-12 2009-12-17 Oral pharmaceutical solutions containing telbivudine ZA200908993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07112381 2007-07-12

Publications (1)

Publication Number Publication Date
ZA200908993B true ZA200908993B (en) 2010-09-29

Family

ID=38724394

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908993A ZA200908993B (en) 2007-07-12 2009-12-17 Oral pharmaceutical solutions containing telbivudine

Country Status (22)

Country Link
US (1) US8445457B2 (xx)
EP (1) EP2178503A1 (xx)
JP (1) JP5314014B2 (xx)
KR (3) KR20120078754A (xx)
CN (1) CN101686938B (xx)
AR (1) AR067630A1 (xx)
AU (1) AU2008274170B2 (xx)
BR (1) BRPI0815562A2 (xx)
CA (1) CA2693609A1 (xx)
CL (1) CL2008002025A1 (xx)
CO (1) CO6270204A2 (xx)
EC (1) ECSP109871A (xx)
IL (1) IL202961A (xx)
MA (1) MA31507B1 (xx)
MY (1) MY147366A (xx)
NZ (1) NZ582443A (xx)
PE (2) PE20130180A1 (xx)
RU (1) RU2493826C2 (xx)
TN (1) TN2010000008A1 (xx)
TW (1) TW200911302A (xx)
WO (1) WO2009007426A1 (xx)
ZA (1) ZA200908993B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105130967B (zh) 2011-05-13 2018-04-17 阵列生物制药公司 作为trka激酶抑制剂的吡咯烷基脲和吡咯烷基硫脲化合物
US20140107130A1 (en) * 2012-10-11 2014-04-17 Antrim Pharmaceuticals, LLC Oral Solution Formulations of Aripiprazole
HUE045340T2 (hu) 2014-05-15 2019-12-30 Array Biopharma Inc 1-((3S,4R)-4-(3-fluorfenil)-1-(2-metoxietil)pirrolidin-3-il)-3-(4-metil-3-(2- metilpirimidin-5-il)-1-fenil-1H-pirazol-5-il)karbamid mint TrkA kináz inhibitor
JP6526904B2 (ja) * 2015-04-26 2019-06-05 マッカイ メモリアル ホスピタルＭａｃｋａｙ Ｍｅｍｏｒｉａｌ Ｈｏｓｐｉｔａｌ 腎疾患を有する患者の腎臓及び／又は心臓機能の改善方法
CN107550866A (zh) * 2016-06-30 2018-01-09 康普药业股份有限公司 一种替比夫定制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
AU9186398A (en) 1997-09-26 1999-04-23 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
DE19817264A1 (de) 1998-04-18 1999-10-21 Bayer Ag Neue Dihydropyrimidine
DE19817265A1 (de) 1998-04-18 1999-10-21 Bayer Ag Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
PE20030545A1 (es) * 2001-10-31 2003-06-19 Schering Corp Formulaciones de jarabe de ribavirina
TWI244393B (en) 2002-08-06 2005-12-01 Idenix Pharmaceuticals Inc Crystalline and amorphous forms of beta-L-2'-deoxythymidine
WO2006130217A2 (en) 2005-04-01 2006-12-07 The Regents Of The University Of California Substituted phosphate esters of nucleoside phosphonates

Also Published As

Publication number Publication date
ECSP109871A (es) 2010-02-26
AR067630A1 (es) 2009-10-21
NZ582443A (en) 2011-04-29
CO6270204A2 (es) 2011-04-20
RU2010104395A (ru) 2011-08-20
AU2008274170A1 (en) 2009-01-15
JP2010533146A (ja) 2010-10-21
TN2010000008A1 (en) 2011-09-26
US8445457B2 (en) 2013-05-21
CN101686938B (zh) 2012-09-05
CN101686938A (zh) 2010-03-31
BRPI0815562A2 (pt) 2015-02-18
MA31507B1 (fr) 2010-07-01
US20100197629A1 (en) 2010-08-05
CA2693609A1 (en) 2009-01-15
RU2493826C2 (ru) 2013-09-27
KR20100029829A (ko) 2010-03-17
MY147366A (en) 2012-11-30
WO2009007426A1 (en) 2009-01-15
PE20130180A1 (es) 2013-03-06
KR20140019040A (ko) 2014-02-13
PE20090476A1 (es) 2009-05-12
AU2008274170B2 (en) 2011-06-09
IL202961A (en) 2013-10-31
EP2178503A1 (en) 2010-04-28
KR20120078754A (ko) 2012-07-10
TW200911302A (en) 2009-03-16
CL2008002025A1 (es) 2009-05-08
JP5314014B2 (ja) 2013-10-16

Similar Documents

Publication Publication Date Title
IL206159A0 (en) Oral pharmaceutical dosage forms
PL2086458T3 (pl) System do higieny jamy ustnej
ZA200809067B (en) Oral care regimen
PT2077729E (pt) Formas orais probióticas
ZA201002255B (en) Orodispersible tablets
PL2399580T3 (pl) Farmaceutyczne postacie dawkowania
EP2133096A4 (en) IN THE MOUTHING TABLET
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
SI2167033T1 (sl) Odmerna oblika, ki obsega takrolimus, za dajanje enkrat na dan
EP2205218A4 (en) ESOMEPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION
GB0710439D0 (en) Oral dosage form
ZA200908993B (en) Oral pharmaceutical solutions containing telbivudine
EP1858493A4 (en) SYSTEM FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
IL198760A0 (en) Oral formulations
IL198160A0 (en) Pharmaceutical formulations
PL2046268T3 (pl) Kompozycja do pielęgnacji jamy ustnej
SI2174652T1 (sl) Oralna farmacevtska sestava desmopresina
HK1141455A (en) Oral pharmaceutical solutions containing telbivudine
TWI340043B (en) Oral drug delivery system
GB0615461D0 (en) Pharmaceutical formulations
GB0713093D0 (en) Pharmaceutical formulations
PH32006000852S1 (en) Pharmaceutical tablet
GB0616860D0 (en) Mouth Snagger
GB0614457D0 (en) Pharmaceutical Combinations
GB0625433D0 (en) Pharmaceutical combinations